Sign Up And Receive Our Latest Promotions!
.svg){kind=small}
Our latest
Press Releases & Updates
Latest press releases
Ikerian Announces Series B Funding First close of USD 8M Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe
RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease
.png)
Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models
.png)
Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing
Latest updates
Swiss AI Day: Empower your business [JUNE'17]
RetinAI will be participating in the Swiss AI Day: EmPOWER your Business, taking place on June 14th in Bern, and featuring top speakers in finance, insurance, healthcare, life sciences and research in AI. Don't miss the date and register now!
ARVO 2017, Baltimore [MAY'17]
Our team members travelled to the American Research in Vision and Ophthalmology (ARVO) conference 2017, in Baltimore, to present their products in the field of OCT image analysis and Fundus Imaging.
Ready for MICCA! [MAY'17]
RetinAI + UniBern's collaboration on Optical Coherence Tomography (OCT) has outcome in a publication in the prestigious conference MICCAI'2017. Meet the RetinAI team in Quebec this September and have some discussions about Machine Learning in Ophthalmology.
Contact us for more informations! We are happy to hear from you!
Ikerian AG (HQ)
Freiburgstrasse 3
3010 Bern
Switzerland
RetinAI US Inc. (US)
6 Liberty Square
#2498 Boston, MA 02109
United States
Imprint/Legal Notice | Data Processing Agreement | Privacy Notice | Created by Ikerian AG. All rights reserved 2016-2023 ©